List of Publications: Professor Tasuku Honjo Awarded the Nobel Prize
投稿日 2018-12-11 | カテゴリ： Library NetworkThe 2018 Nobel Prize in Physiology or Medicine has been awarded in part to Tasuku Honjo, distinguished professor and deputy director-general at the Kyoto University Institute for Advanced Study (KUIAS).
- 2018 Nobel Prize in Physiology or Medicine awarded to Distinguished Professor Tasuku Honjo (1 October 2018) (Kyoto University)
- Tasuku Honjo speaks at a press conference following Nobel announcement (1 October 2018) (Kyoto University)
- The 2018 Nobel Prize in Physiology or Medicine - Press Release （The Official Web Site of the Nobel Prize）
■ Key publication
（All Free）
- Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
Y. Ishida, Y. Agata, K. Shibahara, T. Honjo.
EMBO Journal, 11, 3887-3895 (1992).
DOI: 10.1002/j.1460-2075.1992.tb05481.x
Full Text (Publisher): https://onlinelibrary.wiley.com/doi/abs/10.1002/j.1460-2075.1992.tb05481.x
Full Text (PMC site): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC556898/ - Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor.
Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T.
Immunity, 11, 141-151 (1999).
DOI: 10.1016/S1074-7613(00)80089-8
Full Text (Publisher): https://www.sciencedirect.com/science/article/pii/S1074761300800898?via%3Dihub
Full Text (PMC site): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC556898/ - Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitsz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R., Carreno, B. M., Collins, M., Wood, C. R. and Honjo, T.
Journal of Experimental Medicine, 192, 1027-1034 (2000).
DOI: 10.1084/jem.192.7.1027
Full Text (Publisher): http://jem.rupress.org/content/192/7/1027
Full Text (PMC site): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193311/ - PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells.
Iwai, Y., Terawaki, S., & Honjo, T.
International Immunology, 17(2), 133–144 (2005).
DOI: 10.1093/intimm/dxh194
Full Text (Publisher): https://academic.oup.com/intimm/article/17/2/133/843513
■ The Selected List of Publications of Professor Tasuku Honjo
Reference: CV & Selected Publications (Department of Immunology and Genomic Medicine, Kyoto University Graduate School of Medicine)
#We will continue to update this list.
#A subscription may be required to access the full text in some cases.
◆Studies on Immuno-inhibotory receptor PD-1
- Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
Y. Ishida, Y. Agata, K. Shibahara, T. Honjo.
EMBO J. 11 3887-3895 (1992).
DOI: 10.1002/j.1460-2075.1992.tb05481.x - Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor.
Nishimura, H., Nose, M., Hiai, H., Minato, N. and Honjo, T.
Immunity 11 141-151 (1999).
DOI: 10.1016/S1074-7613(00)80089-8 - Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitsz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., Horton, H. F., Fouser, L., Carter, L., Ling, V., Bowman, M. R., Carreno, B. M., Collins, M., Wood, C. R. and Honjo, T.
J. Exp. Med. 192 1027-1034 (2000).
DOI: 10.1084/jem.192.7.1027 - PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman, Y., Wood, C., Chernova, T., Borde, M., Chernova, I., Iwai, Y., Malenkovich, N., Long, A., Bourque, K., Boussiotis, V., Nishimura, H., Honjo, T., Sharpe, A. and Freeman, G.
Nature Immunol. 2 261-268 (2001)
DOI: 10.1038/85330
Share this article: https://rdcu.be/8mps - Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice.
Nishimura, H., Tanaka, Y., Okazaki, T., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Hiai, H., Minato, N. and Honjo, T.
Science 291 319-322 (2001)
DOI: 10.1126/science.291.5502.319 - Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.
Iwai, Y., shida, M., Tanaka, Y., Okazaki, T., Honjo, T. and Minato, N.
Proc. Natl. Acad. Sci. USA 99 12293-12297 (2002)
DOI: 10.1073/pnas.192461099 - Autoantibodies against cardiac troponin I are responsible for the dilated cardiomyopathy in PD-1 deficient mice.
Okazaki, T., Tanaka, Y., Nishio, R., Mitsuie, T., Mizoguchi, A., Jian, W., Ishida, M., Matsumori, A., Minato,. N. and Honjo, T.
Nature Medicine 9 1477-1483 (2003)
DOI: 10.1038/nm955
Share this article: https://rdcu.be/8mqV - Rejuvenating exhausted T cells during chronic viral infection.
Okazaki T, Honjo T.
Cell. 124(3):459-61 (2006)
DOI: 10.1016/j.cell.2006.01.022 - Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.
Hamanishi J, Mandai M, Iwasaki M, Okazaki T, Tanaka Y, Yamaguchi K, Higuchi T, Yagi H, Takakura K, Minato N, Honjo T, Fujii S.
PNAS. 104(9):3360-5 (2007)
DOI: 10.1073/pnas.0611533104 - TRIM28 prevents autoinflammatory T cell development in vivo.
Chikuma S, Suita N, Okazaki IM, Shibayama S, Honjo T.
Nat Immunol. 13(6):596-603 (2012)
DOI: 10.1038/ni.2293
Share this article: https://rdcu.be/8mrs - A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application.
Okazaki T, Chikuma S, Iwai Y, Fagarasan S, Honjo T.
Nat Immunol. 14(12):1212-8 Review (2013)
DOI: 10.1038/ni.2762
Share this article: https://rdcu.be/8mrJ
KURENAI: http://hdl.handle.net/2433/193052
◆Doctoral Dissertation
- ADENOSINE DIPHOSPHATE RIBOSYLATION OF AMINOACYL TRANSFERASE II AND INHIBITION OF PROTEIN SYNTHESIS BY DIPHTHERIA TOXIN.
（アミノアシルトランスフェラーゼIIのADPリボシル化とジフテリア毒素による蛋白質合成の阻害）
Honjo, Tasuku (本庶, 佑)
Kyoto University, Ph.D. in Medical Science, 医博第463号
Date Granted: January 23, 1975
Abstract: KURENAI: http://hdl.handle.net/2433/220563
◆Articles in Kyoto University Research Information Repository KURENAI (other than that above)
- AID-induced decrease in topoisomerase 1 induces DNA structural alteration and DNA cleavage for class switch recombination.
Maki Kobayashi, Masatoshi Aida, Hitoshi Nagaoka, Nasim A. Begum, Yoko Kitawaki, Mikiyo Nakata, Andre Stanlie, Tomomitsu Doi, Lucia Kato, Il-mi Okazaki, Reiko Shinkura, Masamichi Muramatsu, Kazuo Kinoshita, and Tasuku Honjo.
PNAS, 106 (52), 22375-22380 (2009).
DOI: 10.1073/pnas.0911879106
KURENAI: http://hdl.handle.net/2433/88967
Kyoto University Press Release : AIDによるクラススイッチの際DNA切断を起こすのはトポイソメラーゼ1であることを発見. （2009年12月8日） - B cell–specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers.
Thinh Huy Tran, Mikiyo Nakata, Keiichiro Suzuki, Nasim A Begum, Reiko Shinkura, Sidonia Fagarasan, Tasuku Honjo & Hitoshi Nagaoka.
Nature Immunology, 11, 148–154 (2010)
DOI: 10.1038/ni.1829
KURENAI: http://hdl.handle.net/2433/88755
Kyoto University Press Release: ゲノムに抗体の記憶を刻むAID蛋白質遺伝子（Aicda）の発現制御機構－何故非Bリンパ球にAIDが発現し、癌化が起こり得るのか－を解明しました。（2009年12月7日） - Histone3 lysine4 trimethylation regulated by the facilitates chromatin transcription complex is critical for DNA cleavage in class switch recombination.
Andre Stanlie, Masatoshi Aida, Masamichi Muramatsu, Tasuku Honjo, and Nasim A. Begum.
PNAS, 107 (51) 22190-22195 (2010)
DOI: 10.1073/pnas.1016923108
KURENAI: http://hdl.handle.net/2433/141990 - Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation.
Il-mi Okazaki, Katsuya Okawa, Maki Kobayashi, Kiyotsugu Yoshikawa, Shimpei Kawamoto, Hitoshi Nagaoka, Reiko Shinkura, Yoko Kitawaki, Hisaaki Taniguchi, Tohru Natsume, Shun-Ichiro Iemura, and Tasuku Honjo.
PNAS, 2011 108 (19) 7920-7925 (2011)
DOI: 10.1073/pnas.1104423108
KURENAI: http://hdl.handle.net/2433/141951 - Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation.
Maki Kobayashi, Zahra Sabouri, Somayeh Sabouri, Yoko Kitawaki, Yves Pommier, Takaya Abe, Hiroshi Kiyonari, and Tasuku Honjo.
PNAS, 2011 108 (48) 19305-19310 (2011)
DOI: 10.1073/pnas.1114522108
KURENAI: http://hdl.handle.net/2433/152359 - Activation-Induced Cytidine Deaminase Expression in CD4(+)T Cells is Associated with a Unique IL-10-Producing Subset that Increases with Age.
Hongyan Qin, Keiichiro Suzuki, Mikiyo Nakata, Shunsuke Chikuma, Nakako Izumi, Le Thi Huong, Mikako Maruya, Sidonia Fagarasan, Meinrad Busslinger, Tasuku Honjo , Hitoshi Nagaoka.
PLoS ONE 6(12): e29141.
DOI: 10.1371/journal.pone.0029141
KURENAI: http://hdl.handle.net/2433/152386 - Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes.
Lucia Kato, Nasim A. Begum, A. Maxwell Burroughs, Tomomitsu Doi, Jun Kawai, Carsten O. Daub, Takahisa Kawaguchi, Fumihiko Matsuda, Yoshihide Hayashizaki, and Tasuku Honjo.
PNAS,109 (7) 2479-2484 (2012)
DOI: 10.1073/pnas.1120791109
KURENAI: http://hdl.handle.net/2433/154776 - RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase.
Guoxin Liang, Kouichi Kitamura, Zhe Wang, Guangyan Liu, Sajeda Chowdhury, Weixin Fu, Miki Koura, Kousho Wakae, Tasuku Honjo, and Masamichi Muramatsu
PNAS, 110 (6) 2246-2251 (2013)
DOI: 10.1073/pnas.1221921110
KURENAI: http://hdl.handle.net/2433/171383 - Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response.
Yuxiang Rui, Tasuku Honjo, and Shunsuke Chikuma
PNAS, 110 (40) 16073-16078 (2013)
DOI: 10.1073/pnas.1315828110
KURENAI: http://hdl.handle.net/2433/178757
Kyoto University Press Release: 免疫のブレーキPD-1が、自然免疫反応の調節によって免疫難病の発症を抑制することを解明. （2013年9月17日） - C-terminal region of activation-induced cytidine deaminase (AID) is required for efficient class switch recombination and gene conversion.
Somayeh Sabouri, Maki Kobayashi, Nasim A. Begum, Jianliang Xu, Kouji Hirota, and Tasuku Honjo.
PNAS, 111 (6) 2253-2258 (2014)
DOI: 10.1073/pnas.1324057111
KURENAI: http://hdl.handle.net/2433/183988 - Chromatin remodeller SMARCA4 recruits topoisomerase 1 and suppresses transcription-associated genomic instability.
Afzal Husain, Nasim A. Begum, Takako Taniguchi, Hisaaki Taniguchi, Maki Kobayashi & Tasuku Honjo.
Nature Communications, 7: 10549 (2016)
DOI: 10.1038/ncomms10549
KURENAI: http://hdl.handle.net/2433/210233 - Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Baihao Zhang, Shunsuke Chikuma, Shohei Hori, Sidonia Fagarasan, and Tasuku Honjo
PNAS, 113 (30) 8490-8495 (2016)
DOI: 10.1073/pnas.1608873113
KURENAI: http://hdl.handle.net/2433/216040
Kyoto University Press Release: 免疫のブレーキPD-1は、制御性T細胞との役割分担によって自己免疫性膵炎を抑制する. （2016年7月20日） - Cancer immunotherapies targeting the PD-1 signaling pathway.
Yoshiko Iwai, Junzo Hamanishi, Kenji Chamoto and Tasuku Honjo.
Journal of Biomedical Science, 24:26 (2017)
DOI: 10.1186/s12929-017-0329-9
KURENAI: http://hdl.handle.net/2433/225265
◆Articles in Japanese
本庶佑京都大学名誉教授の医中誌収録文献 (Japan Medical Abstracts Society (JAMAS))
(Academic Support Section, Kyoto University Library)
